Akari Therapeutics Cash Flow Statement (2014-2026) | AKTX

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-0.01B-0.00B-0.00B-20.46B-0.01B-0.01B-0.00B-0.00B-0.00B-0.01B-0.01B-0.01B-0.00B-0.00B-0.00B-0.00B-0.01B-0.01B-0.01B
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)
0.00B
Deferred Taxes (Quarter)
-0.00B
Gains from Sales and Divestitures (Quarter)
0.00B
Gains from Investment Securities (Quarter)
0.00B
Asset Writedowns and Impairment (Quarter)
0.00B
Non-cash Items (Quarter)
0.00B
Cash from Operations (Quarter)
-0.00B
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
Amortization of Goodwill (Quarter)
0.01B
Amortization (Quarter)
0.00B0.00B
Depreciation & Amortization (CF) (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B
Change in Working Capital
Change in Account Payables (Quarter)
Change in Accured Expenses (Quarter)
0.00B
Other Working Capital Changes (Quarter)
0.00B
Investing Activities
Capital Expenditures (Quarter)
Change in Intangibles (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Change in Acquisitions & Divestments (Quarter)
Cash from Investing Activities (Quarter)
Financing Activities
Other financing activities (Quarter)
0.00B0.00B0.00B-0.00B0.00B
Cash from Financing Activities (Quarter)
0.00B
Debt Issuance and Repayment
Non-Current Debt (Quarter)
Additional items
Exchange Rate Effect (Quarter)
0.00B-0.00B-0.00B-1.55B-0.00B-0.00B-0.00B0.00B-0.00B-0.00B0.00B0.00B-0.00B
Change in Cash (Quarter)
-0.00B
Beginning Cash Balance (Quarter)
Free Cash Flow (Quarter)
-0.00B
Net Cash Flow (Quarter)
-0.00B